Items where authors include "Goodman, A.L."

Article

di Martino, E., Nelson, E.A., Nixon, J.E. et al. (4 more authors) (2024) Clinical perspectives on sampling and processing approaches for the management of infection in diabetic foot ulceration: A qualitative study. International Wound Journal, 21 (6). e14912. ISSN 1742-4801

Shaw, R.H., Greenland, M., Stuart, A.S.V. et al. (37 more authors) (2023) Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – a single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines. Journal of Infection, 86 (6). pp. 574-583. ISSN 0163-4453

Liu, X., Munro, A.P., Feng, S. et al. (56 more authors) (2023) Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]. Journal of Infection, 86 (5). pp. 540-541. ISSN 0163-4453

Mentzer, A.J. orcid.org/0000-0002-4502-2209, O’Connor, D. orcid.org/0000-0002-6902-9886, Bibi, S. et al. (66 more authors) (2023) Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection. Nature Medicine, 29 (1). pp. 147-157. ISSN 1078-8956

Brown, M., Saund, J., Qureshi, A. et al. (14 more authors) (2022) Demographics and outcomes of initial phase of COVID-19 medicines delivery units across 4 UK centers during peak B1.1.529 Omicron epidemic: a service evaluation. Open Forum Infectious Diseases, 9 (10). ofac527. ISSN 2328-8957

Munro, A.P.S., Feng, S., Janani, L. et al. (362 more authors) (2022) Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. The Lancet Infectious Diseases, 22 (8). pp. 1131-1141. ISSN 1473-3099

Liu, X., Munro, A.P.S., Feng, S. et al. (56 more authors) (2022) Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. Journal of Infection, 84 (6). pp. 795-813. ISSN 0163-4453

Stuart, A.S.V., Shaw, R.H., Liu, X. et al. (40 more authors) (2022) Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. The Lancet, 399 (10319). pp. 36-49. ISSN 0140-6736

Minassian, A.M., Silk, S.E., Barrett, J.R. et al. (47 more authors) (2021) Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination. Med, 2 (6). 701-719.e19. ISSN 2666-6340